Related references
Note: Only part of the references are listed.miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1
Haibin Yan et al.
ANTI-CANCER DRUGS (2018)
BCRP/ABCG2 and high-alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications
Daiki Hira et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Cohort
Kelly J. Hunt et al.
DIABETES CARE (2018)
lncRNA PFAL promotes lung fibrosis through CTGF by competitively binding miR-18a
Xuelian Li et al.
FASEB JOURNAL (2018)
Connective tissue growth factor (CTGF) from basics to clinics
Yasaman Ramazani et al.
MATRIX BIOLOGY (2018)
Generation of multidrug resistant human tissues by overexpression of the ABCG2 multidrug transporter in embryonic stem cells
Zsuzsa Erdei et al.
PLOS ONE (2018)
Forecast of actin-binding proteins as the oncotarget in osteosarcoma - a review of mechanism, diagnosis and therapy
Yucheng Fu et al.
ONCOTARGETS AND THERAPY (2018)
Overcoming chemoresistance in pancreatic cancer cells: role of the bitter taste receptor T2R10
Louisa Stern et al.
JOURNAL OF CANCER (2018)
Vascular Endothelial Cell-Specific Connective Tissue Growth Factor (CTGF) Is Necessary for Development of Chronic Hypoxia-Induced Pulmonary Hypertension
Liya Pi et al.
FRONTIERS IN PHYSIOLOGY (2018)
Osteosarcoma: Accelerating Progress Makes for a Hopeful Future
Amanda J. Saraf et al.
FRONTIERS IN ONCOLOGY (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
Buccal Mucosal Epithelial Cells Downregulate CTGF Expression in Buccal Submucosal Fibrosis Fibroblasts
Sanjay Gottipamula et al.
JOURNAL OF MAXILLOFACIAL & ORAL SURGERY (2018)
Possible Role of microRNA-122 in Modulating Multidrug Resistance of Hepatocellular Carcinoma
Shaymaa M. M. Yahya et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2018)
Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1
Yun-Gil Roh et al.
BMB REPORTS (2018)
CCN2 induces cellular senescence in fibroblasts
Joon-Ii Jun et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2017)
CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/ plus ) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD)
Stefan Gauer et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2017)
miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin
Shu-Nan Wang et al.
MOLECULAR THERAPY (2017)
What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
Gaia Palmini et al.
MOLECULES (2017)
Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling
Huijun Zeng et al.
CELL DEATH & DISEASE (2017)
MicroRNA-100 suppresses human osteosarcoma cell proliferation and chemo-resistance via ZNRF2
Qiang Xiao et al.
ONCOTARGET (2017)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells
Yangling Li et al.
STEM CELL REPORTS (2017)
MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy
Yichen Meng et al.
SCIENTIFIC REPORTS (2017)
Reversal of ABCB1 mediated efflux by imatinib and nilotinib in cells expressing various transporter levels
Petr Mlejnek et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene
Youguang Pu et al.
BMC CANCER (2017)
Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets
Guang-Ning Yan et al.
CANCER LETTERS (2016)
CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer
Kai Yang et al.
ONCOTARGETS AND THERAPY (2016)
MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells
Yusheng Li et al.
ONCOLOGY LETTERS (2016)
Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse
Matthieu Corvaisier et al.
ONCOTARGET (2016)
MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1
Bo-chuan Lin et al.
MEDICAL SCIENCE MONITOR (2016)
Cell surface receptors for CCN proteins
Lester F. Lau
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2016)
Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer
Julia E. Wells et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
CTGF increases drug resistance to paclitaxel by upregulating survivin expression in human osteosarcoma cells
Hsiao-Chi Tsai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
CCN2 Enhances Resistance to Cisplatin-Mediating Cell Apoptosis in Human Osteosarcoma
Hsiao-Chi Tsai et al.
PLOS ONE (2014)
CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d
Hsiao-Chi Tsai et al.
ONCOTARGET (2014)
Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics
Kohji Noguchi et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2014)
CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer
Albrecht Neesse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Overlapping Substrate and Inhibitor Specificity of Human and Murine ABCG2
Joshua Bakhsheshian et al.
DRUG METABOLISM AND DISPOSITION (2013)
CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells
Lei Cui et al.
TUMOR BIOLOGY (2011)
Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme
Dong Yin et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: Potential involvement of ABCG2
Xiaodong Wang et al.
DRUG METABOLISM AND DISPOSITION (2007)
All in the CCN family: essential matricellular signaling modulators emerge from the bunker
Andrew Leask et al.
JOURNAL OF CELL SCIENCE (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin
YL Chen et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
The heparin-binding 10 kDa fragment of connective tissue growth factor (CTGF) containing module 4 alone stimulates cell adhesion
DK Ball et al.
JOURNAL OF ENDOCRINOLOGY (2003)
Matricellular proteins: extracellular modulators of cell function
P Bornstein et al.
CURRENT OPINION IN CELL BIOLOGY (2002)
Neoplastic cells and proliferating endothelial cells express connective tissue growth factor (CTGF) in glioblastoma
LH Pan et al.
NEUROLOGICAL RESEARCH (2002)
A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2)
RW Robey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Share Paper
